Connection

Gunnar Gislason to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Back to Details
This is a "connection" page, showing publications Gunnar Gislason has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Gunnar Gislason
Connection Strength
0.148
Hydroxymethylglutaryl-CoA Reductase Inhibitors
  1. Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study. BMJ Open. 2020 12 04; 10(12):e044421.
    View in: PubMed
    Score: 0.093
  2. Burden and Causes of Hospital Admissions in Heart Failure During the Last Year of Life. JACC Heart Fail. 2019 07; 7(7):561-570.
    View in: PubMed
    Score: 0.021
  3. Mortality associated with cardiovascular drugs in patients with chronic obstructive pulmonary disease and right-sided heart failure - A danish nationwide registry-based study. Eur J Intern Med. 2019 May; 63:56-61.
    View in: PubMed
    Score: 0.021
  4. Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains. Circulation. 2012 Sep 11; 126(11):1345-54.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.